Company / Total Assets
Xenon Pharmaceuticals Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$633.2M
FY2025
5-year range
$572.0M / $964.8M
FY2021-FY2025
Trend
-20.7%
vs FY2024
Sector context
#118 of 214
Health Care
What the data says
At $633M, Xenon Pharmaceuticals Inc.'s total assets ranks #118 of 214 in the Health Care sector. Declined from $965M to $633M over the past 2 years.
Based on SEC 10-K filings.
$633M in FY2025 with a 5-year CAGR of +27.3%.
Declined from $965M to $633M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- +27.3%
- 10-Year CAGR
- -
Sector benchmark
#118 of 214 in Health CareTop 55% of 214This company $633.2M Sector average $7.5B
▼
-91.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +27.3%, indicating consistent growth.
- In FY2025, total assets decreased 20.7% year-over-year.
- Ranks #118 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $633.2M | -20.7% |
| FY2024 | $798.1M | -17.3% |
| FY2023 | $964.8M | +27.9% |
| FY2022 | $754.1M | +31.8% |
| FY2021 | $572.0M | +202.4% |
| FY2020 | $189.2M | +28.1% |
| FY2019 | $147.7M | +20.6% |
| FY2018 | $122.4M | +165.4% |
| FY2017 | $46.1M | -31.7% |
| FY2016 | $67.5M | +5.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026